UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):  July 15, 2019

 

CYNERGISTEK, INC.

(Exact name of registrant as specified in its charter)

 

DELAWARE

(State or other jurisdiction of incorporation)

 

000-27507

37-1867101

(Commission File Number)

(I.R.S. Employer Identification No.)

 

11940 Jollyville Road, Suite 300-N

Austin, Texas  78759

(Address of principal executive offices)

 

(512) 402-8550

(Registrant’s telephone number, including area code)

 

N/A

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934:

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $0.001 par value

CTEK

NYSE American

 

 

  Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).


Emerging growth company   

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  


 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.  

 

Retirement of Michael “Mac” McMillan and Appointment of Caleb Barlow

 

On July 15, 2019, Michael “Mac” McMillan notified the Board of Directors (the “Board”) of CynergisTek, Inc.  (the “Company”), of his decision to retire from the Company effective December 31, 2019.  In connection with his planned retirement, Mr. McMillan also submitted his resignation as President and Chief Executive Officer of the Company, effective July 31, 2019.  The Board has appointed William Caleb Barlow, 47, to succeed Mr. McMillan as President and Chief Executive Officer of the Company, effective August 1, 2019.  Mr. Barlow was also appointed to fill a newly created seat on the Board and will receive no additional compensation for his service as a director.  Mr. Barlow’s committee assignments have not yet been determined. Mr. Barlow’s appointment is the result of a thorough leadership succession plan that was developed by senior management of the Company under the direction and oversight of Mr. McMillan and the Board. Mr. McMillan’s resignation as President and Chief Executive Officer is not due to any dispute or disagreement over the Company’s operations, practices or policies.  Mr. McMillan will continue to serve as a director of the Company and will remain employed by the Company through his retirement date in order to assist with the transition.  Mr. McMillan was given the honorary title of President and CEO Emeritus by the Board.  

 

Barlow Employment Agreement and Experience

 

In connection with Mr. Barlow’s appointment, on July 15, 2019, the Company and Mr. Barlow entered into an employment agreement (the “Employment Agreement”) to be effective as of August 1, 2019.  Pursuant to the Employment Agreement, Mr. Barlow will have the duties and responsibilities as are commensurate with the positions of President and Chief Executive Officer, as reasonably and lawfully directed by the Board.   The initial term of the Employment Agreement is 36 months from August 1, 2019 and will automatically renew for subsequent 12-month terms unless either party provides written notice to the other party of a desire not to renew employment. 

 

Pursuant to the Employment Agreement, Mr. Barlow’s base salary will be $350,000, and he is entitled to incentive bonus compensation, equity compensation consisting of an option to purchase up to 500,000 shares of the Company’s common stock, subject to vesting, restricted stock units, and a sign-on and retention bonus, all as set forth in the Employment Agreement.  The options to purchase common stock are nonqualified stock options and were granted pursuant to a Stock Option Grant Agreement between the Company and Mr. Barlow.  The stock option grant was made outside of the Company's 2011 Stock Incentive Plan and was approved by the Compensation Committee of the Company's Board of Directors. The sign-on and retention bonus is paid in three tranches through 2021.  The Company has the right to terminate Mr. Barlow’s employment without cause at any time on thirty (30) days’ advance written notice to Mr. Barlow. Additionally, Mr. Barlow has the right to resign for “Good Reason” (as defined in the Employment Agreement) on thirty (30) days’ written notice.  In the event of (i) such termination without cause, or (ii) Mr. Barlow’s inability to perform the essential functions of his position due to a mental or physical disability or his death, or (iii) Mr. Barlow’s resignation for Good Reason, Mr. Barlow is entitled to receive (a) his annual base salary then in effect, and full target annual bonus, each prorated to the date of termination, (b) payment of base salary compensation for an additional twelve months, payable as a lump sum, (c) acceleration and payment of the unpaid portion of the sign-on and retention bonus, and (d) the acceleration of all unvested stock options and warrants then held by Mr. Barlow, subject to certain conditions set forth in the Employment Agreement.  If Mr. Barlow resigns for any reason other than Good Reason, he will be entitled to receive his base salary for the thirty (30) day written notice period, but no other amounts. 

 

The preceding description of the Employment Agreement is a summary of its material terms, does not purport to be complete, and is qualified in its entirety by reference to the Employment Agreement, a copy of which is being filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference.

 

Since 2003, Mr. Barlow has served in various leadership positions with International Business Machines Corporation (IBM) in Massachusetts, including as Vice President of Mobile Management and Security and Vice President of Marketing for IBM Security.  Most recently, and since January 2017, Mr. Barlow served as Vice President of X-Force Threat Intelligence at IBM Security, where he led this organization for more than two years


and built X-Force Command in 2016. Mr. Barlow was a key leader in developing IBM’s comprehensive incident command system for responding to major cyber incidents, and created the industry’s first immersive cyber range and the first mobile cyber operations center. Additionally, Mr. Barlow invented and launched the Cyber Tactical Operations Center which is a first-of-its-kind training, simulation, and security operations center on wheels.

 

Mr. Barlow has a broad background in general management, strategy, marketing, services, product development, product management and leading technical teams in cloud service delivery. He has extensive mergers and acquisitions experience, having led the acquisition and roll up of several cyber companies into IBM. The organizations he has led within IBM have ranged from small to enterprise level businesses.  

 

There are no arrangements or understandings between Mr. Barlow and any other persons pursuant to which he was appointed as President and Chief Executive Officer or director. There are also no family relationships between Mr. Barlow and any of our directors or executive officers, and he has no direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K, other than as set forth herein.

 

Item 7.01 Regulation FD Disclosure  

 

On July 15, 2019 the Company issued a press release announcing the retirement of Mr. McMillan and the appointment of Mr. Barlow.  A copy of the press release is furnished herewith as Exhibit 99.1.

 

Item 9.01 Financial Statements and Exhibits  

 

(d) Exhibits.

 

Exhibit No.

Description of Exhibit

 

 

10.1

99.1

Employment Agreement

Press Release

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

CYNERGISTEK, INC.

 

 

Date:   

July 16, 2019

By:

/s/ Paul T. Anthony

Name:

Paul T. Anthony

Title:

Chief Financial Officer

 

4812-4359-4140

EXECUTIVE EMPLOYMENT AGREEMENT

THIS EXECUTIVE EMPLOYMENT AGREEMENT (“ Agreement ”) is made effective as of August 1, 2019 (“ Effective Date ”), by and between CynergisTek, Inc., a Delaware corporation (“ Company ”) and Caleb Barlow (“ Executive ”).

The parties agree as follows:

1. Employment . Company hereby employs Executive, and Executive hereby accepts such employment, upon the terms and conditions set forth herein. 

2. Duties

2.1 Position . Executive shall serve as President and Chief Executive Officer of Company, and shall have the duties and responsibilities as are commensurate with such position, as reasonably and lawfully directed by Company’s board of directors (the “ Board of Directors ”) from time to time. Executive shall perform faithfully and diligently all duties assigned to Executive. Company reserves the right to modify Executive’s duties at any time in its sole and absolute discretion.  Executive shall also serve as the President and Chief Executive Officer of CTEK Security, Inc. and such additional subsidiaries and affiliates of Company as Executive and the Board of Directors mutually agree from time to time.   

2.2 Best Efforts/Full-time . Executive will expend Executive’s best efforts on behalf of Company and its subsidiaries, and will abide by all policies and decisions made by Company, as well as all applicable federal, state and local laws, regulations or ordinances. Executive will act in the best interest of Company at all times. Executive shall devote Executive’s full business time and efforts to the performance of Executive’s assigned duties for Company, unless Executive notifies the Board of Directors in advance of Executive’s intent to engage in other paid work and receives the Board of Directors’ express written consent to do so. 

3. Term

3.1 Initial Term . The employment relationship pursuant to this Agreement shall be for an initial term commencing on the Effective Date set forth above and continuing for a period of thirty-six (36) months (“ Initial Term ”), unless sooner terminated in accordance with Section 7 below. 

3.2 Renewal . On completion of the Initial Term specified in Section 3.1 above, this Agreement will automatically renew for subsequent twelve (12) month terms unless either party provides at least 60 days’ advance written notice to the other that such party does not wish to renew the Agreement for a subsequent twelve (12) months. In the event either party gives notice of nonrenewal pursuant to this Section 3.2, this Agreement will expire at the end of the current term.  

4. Compensation

4.1 Base Salary . As compensation for Executive’s performance of Executive’s duties hereunder, Company shall pay to Executive the amount set forth in the Exhibit A (the “ Base Salary ”), payable in accordance with the normal payroll practices of Company, less required deductions for state and federal withholding tax, social security and all other employment taxes and  


4833-0880-5017


payroll deductions. In the event Executive’s employment under this Agreement is terminated by either party, for any reason, Executive will be entitled to receive Executive’s Base Salary prorated to the date of termination.

4.2 Incentive Compensation . Executive will be eligible to earn incentive compensation in accordance with the provisions set forth in Exhibit A

5. Customary Fringe Benefits . Executive will be eligible for all customary and usual fringe benefits generally available to executives of Company, subject to the terms and conditions of Company’s benefit plan documents. Company reserves the right to change or eliminate the fringe benefits on a prospective basis, at any time, effective upon notice to Executive. 

6. Business Expenses . Executive will be reimbursed for all reasonable, out-of-pocket business expenses incurred in the performance of Executive’s duties on behalf of Company. To obtain reimbursement, expenses must be submitted promptly with appropriate supporting documentation in accordance with Company’s policies. 

7. Termination of Executive’s Employment .  

7.1 Termination for Cause by Company . Although Company anticipates a mutually rewarding employment relationship with Executive, Company may terminate Executive’s employment immediately at any time for Cause. For purposes of this Agreement, “ Cause ” is defined as: (a) acts or omissions constituting gross negligence, recklessness or willful misconduct on the part of Executive with respect to Executive’s obligations or otherwise relating to the business of Company; (b) Executive’s material breach of this Agreement; and (c) Executive’s conviction or entry of a plea of nolo contendere for fraud, misappropriation or embezzlement, or any felony or crime of moral turpitude. In the event Executive’s employment is terminated in accordance with this Section 7.1, (i) Executive shall be entitled to receive Executive’s Base Salary prorated to the date of termination, (ii) all other Company obligations to Executive pursuant to this Agreement will become automatically terminated and completely extinguished and (iii) Executive will not be entitled to receive the Severance Payments described in Section 7.2 below. 

7.2 Termination Without Cause by Company; Severance; Change of Control .  

(a) Company may terminate Executive’s employment under this Agreement without Cause at any time on thirty (30) days’ advance written notice to Executive. In the event of (i) such termination without Cause, (ii) Executive’s inability to perform the essential functions of Executive’s position due to a mental or physical disability or Executive’s death, or (iii) in the event of the termination of Executive without Cause following a “Change of Control” (as defined in Section 7.2(b) below), Executive, or Executive’s estate, as applicable, will receive the Base Salary then in effect, prorated to the date of termination and the following “ Severance Payments ”: (w) full target annual bonus, prorated to the date of termination, (x) acceleration and payment of the unpaid portion of Executive’s Sign-on Bonus (as described on Exhibit A ), (y) payment of compensation for an additional twelve (12) months based on the Base Salary then in effect, payable as a lump sum, and (z) the acceleration of all unvested stock options and warrants then held by Executive. All Severance Payments are conditioned on Executive: (i) complying with all surviving provisions of this Agreement as specified in Section 13.9 below; and (ii) executing a full general release, releasing all claims, known or unknown, that Executive may have against Company (and any subsidiaries and  


2

 

4833-0880-5017


affiliates of Company) arising out of or any way related to Executive’s employment or termination of employment with Company (the “ Release ”).  The Severance Payment will be made on the sixtieth (60 th ) day following Executive’s termination of employment provided that the Release has been executed by Executive and become irrevocable prior to such date.  Company will provide the form of Release to Executive within five (5) business days following Executive’s termination.

(b) As used herein, “ Change of Control ” means: (i) a sale of all or substantially all of the assets of Company; (ii) a merger or consolidation in which Company is not the surviving entity and in which the holders of Company’s outstanding voting stock immediately prior to such transaction own, immediately after such transaction, securities representing less than fifty percent (50%) of the voting power of the entity surviving such transaction or, where the surviving entity is a wholly-owned subsidiary of another entity, the surviving entity’s parent; or (iii) a reverse merger in which Company is the surviving entity but the shares of common stock outstanding immediately preceding the merger are converted by virtue of the merger into other property, whether in the form of securities of the surviving entity’s parent, cash or otherwise, and in which the holders of Company’s outstanding voting stock immediately prior to such transaction own, immediately after such transaction, securities representing less than fifty percent (50%) of the voting power of Company or, where Company is a wholly-owned subsidiary of another entity. 

(c) In the event that the benefits provided to Executive under this Agreement, and any other agreements, plans or arrangements to which Executive may be a party with Company, cause Executive to incur an excise tax under Section 4999 of the Internal Revenue Code of 1986 (the “ Code ”) or any corresponding provisions of applicable state tax law in connection with a Change of Control, then Company will pay Executive an additional amount sufficient to reimburse Executive for (i) the excise tax imposed on such benefits, and (ii) the federal and state income, employment and excise taxes, determined on a fully “grossed-up” basis, imposed on the benefits payments provided.  Company shall be entitled to withhold from the payment required hereunder such taxes as it may be required to withhold under applicable tax law, and any such withheld taxes shall be treated as paid to Executive hereunder.  The tax gross-up payments provided for in this Section 7.2(c) shall be paid to Executive as soon as administratively practicable following the date the amount is determined by Executive, but in no event will the payment be made later than the sixtieth (60 th ) day following the end of the taxable year in which the related taxes are remitted to the taxing authority. 

7.3 Voluntary Resignation by Executive for Good Reason . Executive may voluntarily resign Executive’s position with Company for Good Reason, at any time on thirty (30) days’ advance written notice. In the event of Executive’s resignation for Good Reason, Executive will be entitled to receive the Base Salary then in effect, prorated to the date of termination, and the Severance Payments described in Section 7.2 above, provided Executive complies with all of the conditions in Section 7.2 above. All other Company obligations to Executive pursuant to this Agreement will become automatically terminated and completely extinguished. Executive will be deemed to have resigned for “ Good Reason ” in the following circumstances: (a) Company’s material breach of this Agreement; (b) Executive’s Base Salary is reduced by more than 10% below Executive’s salary in effect at any time during the preceding twelve (12) months, unless the reduction is made as part of, and is generally consistent with, a general reduction of senior executive salaries; and (c) Company relocates Executive’s principal place of work to a location more than sixty (60) miles from Executive’s current location, without Executive’s prior written approval.  A termination for Good Reason by Executive shall not occur unless Executive provides Company written notice of the existence of the condition described in clauses (a) – (c) above within a period not to exceed  


3

 

4833-0880-5017


ninety (90) days from the initial existence of the condition stating the basis for the termination for Good Reason.  Company will have the opportunity for a period of thirty (30) days from the receipt of Executive’s notice to cure the condition described as the basis for Executive’s termination for Good Reason.

7.4 Voluntary Resignation by Executive Without Good Reason. Executive may voluntarily resign Executive’s position with Company without Good Reason, at any time, on thirty (30) days’ advance written notice. In the event of Executive’s resignation without Good Reason, Executive will be entitled to receive only the Base Salary for the thirty-day notice period and no other amount for the remaining months of the current term, if any. All other Company obligations to Executive pursuant to this Agreement will become automatically terminated and completely extinguished. In addition, Executive will not be entitled to receive the Severance Payments described in Section 7.2 above. 

7.5 Termination of Employment Upon Nonrenewal . In the event Executive decides not to renew this Agreement for a subsequent twelve (12) months in accordance with Section 3.2 above, the Agreement will expire, Executive’s employment with Company will terminate and Executive will only be entitled to Executive’s Base Salary paid through the last day of the current term. All other Company obligations to Executive pursuant to this Agreement will become automatically terminated and completely extinguished. Executive will not be entitled to the Severance Payments described in Section 7.2 above.  In the event Company decides not to renew this Agreement for a subsequent twelve (12) months after the Initial Term in accordance with Section 3.2 above, it will be deemed a termination without Cause in accordance with Section 7.2 and Executive will be entitled to all compensation including the Severance Payments as outlined in Section 7.2. 

8. No Conflict of Interest .  Executive represents and warrants that (a) Executive is not subject to any contract, arrangement, policy or understanding, or to any statute, governmental rule or regulation, that in any way limits Executive’s ability to enter into and fully perform Executive’s obligations under this Agreement and (b) Executive is not otherwise unable to enter into and fully perform Executive’s obligations under this Agreement.  In the event of a breach of any representation in this Section 8, Company may terminate this Agreement for Cause and Executive’s employment with Company without any liability to Executive and Executive shall indemnify the Company for any liability it may incur as a result of any such breach. 

9. Confidentiality and Proprietary Rights . Executive agrees to read, sign and abide by Company’s Confidentiality, Non-Solicitation and Inventions Agreement, which is provided with this Agreement and incorporated herein by reference. 

10. Restrictive Covenants .  

10.1 Non-Competition .  Executive agrees that, during the term of their employment, Executive shall not, directly or indirectly, on Executive’s own behalf or on behalf of any other third party not affiliated with Company: (A) perform services in the healthcare information technology consulting industry or any other business in which Company or its subsidiaries engage during the term of this Agreement with the involvement of Executive (the “ Business ”) anywhere in the United States of America (the “ Restricted Territory ”), including providing funds for the same; or (B) provide services routinely performed for customers or clients (“ Customers ”) (directly or indirectly) in the operation of the Business (“ Services ”) in the Restricted Territory.   


4

 

4833-0880-5017


10.2 Non-Solicitation .  Executive agrees that, during the term of this Agreement, and for a period of one (1) year after the termination of this Agreement, Executive shall not, directly or indirectly, on Executive’s own behalf or on behalf of any other third party not affiliated with Company: (A) solicit any Customer of the Business for purposes of providing Services; (B) accept as a customer any Customer for purposes of providing Services; (C) induce or attempt to induce any employee, consultant or independent contractor of Company or its subsidiaries to terminate his or her employment or relationship with Company or its subsidiaries; (D) employ, or engage as an independent contractor, any employee, consultant or independent contractor of Company or its subsidiaries; (E) interfere with the business relationship between a Customer or employee and Company or its subsidiaries; or (F) encourage any person to engage in any of the foregoing activities, including but not limited to providing financing, directly or indirectly, for any of the foregoing activities; provided, however, that the foregoing will not restrict the ability of Executive to purchase or otherwise acquire up to two percent of any class of securities of any enterprise (but without otherwise participating in the activities of such enterprise) if such securities have been registered under Section 12(b) or 12(g) of the Securities Exchange Act of 1934. 

10.3 Reasonable Restrictions . Executive hereby agrees that the covenants in this Agreement are reasonable given the real and potential competition encountered (and reasonably expected to be encountered) by Company and the substantial knowledge and goodwill Executive will acquire with respect to the Business.  Executive and Company understand and agree that the purpose of this Section 10 is solely to protect Company’s legitimate business interests, including, but not limited to confidential information and trade secrets, partner relationships and goodwill, and Company’s competitive advantage in the operation of the Business or provision of Services.  Executive and Company further understand and agree that this Section 10 represents an important element of this Agreement, and is a material inducement to Company entering into this Agreement, without which Company would not have entered into this Agreement.  Notwithstanding the foregoing, in the event that at the time of enforcement of any provision of Section 10 a court or other tribunal will hold that the restrictions in Section 10 are unreasonable or unenforceable under circumstances then existing, the parties agree that the maximum period, scope or geographical area reasonable under such circumstances will be substituted for the stated period, scope or area.  

11. Injunctive Relief . Executive acknowledges that Executive’s breach of the covenants contained in this Agreement would cause irreparable injury to Company and agrees that in the event of any such breach, Company shall be entitled to seek temporary, preliminary and permanent injunctive relief without the necessity of proving actual damages or posting any bond or other security. 

12. Agreement to Arbitrate . To the fullest extent permitted by law, Executive and Company agree to arbitrate any controversy, claim or dispute between them arising out of or in any way related to this Agreement, the employment relationship between Company and Executive and any disputes upon termination of employment, including but not limited to breach of contract, tort, discrimination, harassment, wrongful termination, demotion, discipline, failure to accommodate, family and medical leave, compensation or benefits claims, constitutional claims; and any claims for violation of any local, state or federal law, statute, regulation or ordinance or common law. Claims for workers’ compensation, unemployment insurance benefits and Company’s right to obtain injunctive relief pursuant to Section 11 above are excluded. For the purpose of this agreement to arbitrate, references to “Company” include all parent, subsidiary or related entities and their employees, supervisors, officers, directors, agents, pension or benefit plans, pension or benefit plan  


5

 

4833-0880-5017


sponsors, fiduciaries, administrators, affiliates and all successors and assigns of any of them, and this agreement to arbitrate shall apply to them to the extent Executive’s claims arise out of or relate to their actions on behalf of Company.

12.1 Consideration . The mutual promise by Company and Executive to arbitrate any and all disputes between them rather than litigate them before the courts or other bodies, provides the consideration for this agreement to arbitrate. 

12.2 Initiation of Arbitration . Either party may exercise the right to arbitrate by providing the other party with written notice of any and all claims forming the basis of such right in sufficient detail to inform the other party of the substance of such claims. In no event shall the request for arbitration be made after the date when institution of legal or equitable proceedings based on such claims would be barred by the applicable statute of limitations. 

12.3 Arbitration Procedure . The arbitration will be conducted in Austin, Texas by a single neutral arbitrator and in accordance with the then current rules for resolution of employment disputes of the American Arbitration Association. The parties are entitled to representation by an attorney or other representative of their choosing. The arbitrator shall have the power to enter any award that could be entered by a judge of the trial court of the State of Texas, and only such power, and shall follow the law. In the event the arbitrator does not follow the law, the arbitrator will have exceeded the scope of his or her authority and the parties may, at their option, file a motion to vacate the award in court. The parties agree to abide by and perform any award rendered by the arbitrator. Judgment on the award may be entered in any court having jurisdiction thereof. 

12.4 Costs of Arbitration . Each party shall bear one half the cost of the arbitration filing and hearing fees, and the cost of the arbitrator. 

This agreement to arbitrate specifically includes any class-action cases and Executive specifically waives Executive’s right to participate in any class-action against Company.

13. General Provisions

13.1 Successors and Assigns . The rights and obligations of Company under this Agreement shall inure to the benefit of and shall be binding upon the successors and assigns of Company. Executive shall not be entitled to assign any of Executive’s rights or obligations under this Agreement. 

13.2 Waiver . Either party’s failure to enforce any provision of this Agreement shall not in any way be construed as a waiver of any such provision, or prevent that party thereafter from enforcing each and every other provision of this Agreement. 

13.3 Attorneys’ Fees . Each side will bear its own attorneys’ fees in any dispute unless a statutory section at issue, if any, authorizes the award of attorneys’ fees to the prevailing party. 

13.4 Severability . In the event any provision of this Agreement is found to be unenforceable by an arbitrator or court of competent jurisdiction, such provision shall be deemed modified to the extent necessary to allow enforceability of the provision as so limited, it being  


6

 

4833-0880-5017


intended that the parties shall receive the benefit contemplated herein to the fullest extent permitted by law. If a deemed modification is not satisfactory in the judgment of such arbitrator or court, the unenforceable provision shall be deemed deleted, and the validity and enforceability of the remaining provisions shall not be affected thereby.

13.5 Interpretation; Construction . The headings set forth in this Agreement are for convenience only and shall not be used in interpreting this Agreement. This Agreement has been drafted by legal counsel representing Company, but Executive has participated in the negotiation of its terms. Furthermore, Executive acknowledges that Executive has had an opportunity to review and revise the Agreement and have it reviewed by legal counsel, if desired, and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting party shall not be employed in the interpretation of this Agreement. 

13.6 Governing Law . This Agreement will be governed by and construed in accordance with the laws of the United States and the State of Texas. Subjection to Section 12, each party consents to the jurisdiction and venue of the state or federal courts in Travis County, Texas, if applicable, in any action, suit, or proceeding arising out of or relating to this Agreement. 

13.7 Notices. Any notice required or permitted by this Agreement shall be in writing and shall be delivered as follows with notice deemed given as indicated (a) by personal delivery when delivered personally; (b) by overnight courier upon written verification of receipt; (c) by telecopy or facsimile transmission upon acknowledgment of receipt of electronic transmission; or (d) by certified or registered mail, return receipt requested, upon verification of receipt. Notice shall be sent to the addresses set forth below, or such other address as either party may specify in writing. 

13.8 Code Section 409A .   

(a) This Agreement is intended to comply with Code Section 409A (“ Section 409A ”) or an exemption thereunder and shall be construed and administered in accordance with such intent. Notwithstanding any other provision of this Agreement, payments provided under this Agreement may only be made upon an event and in a manner that complies with Section 409A or an applicable exemption. Any nonqualified deferred compensation payments under this Agreement that may be excluded from Section 409A either as separation pay due to an involuntary separation from service or as a short-term deferral shall be excluded from Section 409A to the maximum extent possible. For purposes of Section 409A, each installment payment provided under this Agreement shall be treated as a separate payment. Any payments to be made under this Agreement upon a termination of employment shall only be made upon a “separation from service” under Section 409A. Notwithstanding the foregoing, Company makes no representations that the payments and benefits provided under this Agreement comply with Section 409A, and in no event shall Company be liable for all or any portion of any taxes, penalties, interest, or other expenses that may be incurred by Executive on account of non-compliance with Section 409A.   

 

(b) Notwithstanding any other provision of this Agreement, if any payment or benefit provided to Executive in connection with his termination of employment is determined to constitute “nonqualified deferred compensation” within the meaning of Section 409A and Executive is determined to be a “specified employee” under Section 409A, then such payment or benefit shall not be paid until the first payroll date to occur following the six-month anniversary of the date of Executive’s termination or, if earlier, on Executive’s death (the “ Specified Employee Payment  


7

 

4833-0880-5017


Date ”). The aggregate of any payments that would otherwise have been paid before the Specified Employee Payment Date shall be paid to Executive in a lump sum on the Specified Employee Payment Date and thereafter, any remaining payments shall be paid without delay in accordance with their original schedule.  

 

(c) To the extent required by Section 409A, each reimbursement or in-kind benefit provided under this Agreement shall be provided in accordance with the following:  (i) the amount of expenses eligible for reimbursement, or in-kind benefits provided, during each calendar year cannot affect the expenses eligible for reimbursement, or in-kind benefits to be provided, in any other calendar year; (ii) any reimbursement of an eligible expense shall be paid to Executive on or before the last day of the calendar year following the calendar year in which the expense was incurred; and (iii) any right to reimbursements or in-kind benefits under this Agreement shall not be subject to liquidation or exchange for another benefit.   

 

13.9 Survival . Sections 8, 9, 10, 11, 12, 13 and 14 of this Agreement shall survive Executive’s employment by Company. 

14. Entire Agreement . This Agreement, including the Confidentiality, Non-Solicitation and Inventions Agreement incorporated herein by reference, constitutes the entire agreement between the parties relating to this subject matter and supersedes all prior or simultaneous representations, discussions, negotiations, and agreements, whether written or oral. This Agreement may be amended or modified only with the written consent of Executive and the Board of Directors of Company. No oral waiver, amendment or modification will be effective under any circumstances whatsoever. 

[Signature Page Follows]


8

 

4833-0880-5017



THE PARTIES TO THIS AGREEMENT HAVE READ THE FOREGOING AGREEMENT AND FULLY UNDERSTAND EACH AND EVERY PROVISION CONTAINED HEREIN. WHEREFORE, THE PARTIES HAVE EXECUTED THIS AGREEMENT ON THE EFFECTIVE DATE.

 

By: /s/ Caleb Barlow  

Caleb Barlow

[Address on file with Company]

 

 

 

 

By: /s/ Michael McMillan  

Michael McMillan  

Chief Executive Officer  

CynergisTek, Inc.  

11940 Jollyville Road, Suite 300N  

Austin, TX 78759  


Signature Page to Caleb Barlow Employment Agreement

 

4833-0880-5017


EXHIBIT A

COMPENSATION PLAN

 

Base Salary :

Executive will be entitled to an annual Base Salary for the Initial Term of $350,000

Incentive Compensation :

Executive will be eligible to participate in CynergisTek’s incentive-based bonus plan that offers the potential to receive a discretionary bonus up to 100% of base salary. For 2019, your discretionary bonus will be adjusted and will total up to $85,000. The incentive bonus plan is based on a number of factors established by the Board.

Equity Incentive:

Executive will be eligible for grants of restricted stock units (RSUs) and stock options, as follows:

1. 50,000 RSUs as a participant in the employee annual grant set by the Board prior to the end of the calendar year 2019.  Grant vesting schedule is a 3-year cliff vesting schedule from the grant date. 

2. An option or warrant (form to be finalized and approved by the Board of Directors) to purchase up to 500,000 shares of CynergisTek stock priced at the fair market value on the date of grant.  This Option shall vest as to one-third (1/3rd) on the first anniversary of the date of grant and as to one-third (1/3rd) on the two subsequent anniversaries of the date of grant, such that the Option shall be fully vested on the third (3rd) anniversary of the date of grant. 

Sign-on Bonus:

Executive will be paid a signing and retention bonus of $500,000, as follows:

1. $200,000 paid on the Effective Date.  If you choose to leave CynergisTek prior to the first anniversary of the Effective Date, you will pay CynergisTek back this amount. 

2. $150,000 paid on January 1st, 2020; provided that you must be employed by CynergisTek on this date to receive the payment. If you choose to leave CynergisTek prior to the second anniversary of the Effective Date, you will pay CynergisTek back this amount. 

3. $150,000 paid on January 1st, 2021; provided that you must be employed by CynergisTek on this date to receive the payment. If you choose to leave CynergisTek prior to the third anniversary of the Effective Date, you will pay CynergisTek back this amount. 


10

 

4833-0880-5017

CynergisTek, Inc. Announces Retirement of Founder and Thought Leader Mac McMillan and Appoints His Successor Caleb Barlow as President & Chief Executive Officer to Lead the Company’s Next Stage of Growth.

 

Austin, TX – July 15, 2019 — CynergisTek, Inc. (NYSE AMERICAN: CTEK), today announced the appointment of Caleb Barlow to the positions of President and Chief Executive Officer, to succeed retiring founder and current President and CEO Mac McMillan effective August 1, 2019. McMillan will support Barlow in the execution of CynergisTek’s strategy through the remainder of 2019 and will remain a member of the Board of Directors going forward.

 

“Mr. McMillan’s vision, thought leadership and focused commitment to the healthcare industry grew CynergisTek into the leading healthcare focused cybersecurity, privacy and compliance services company in the U.S. He drove dramatic and consistent year over year growth and made a significant impact to the healthcare industry as a whole,” said JD Abouchar, Chairman of the Board. “ I want to thank him for his dynamic leadership and look forward to his continued support as a member of our Board.”

 

“I want to congratulate Caleb on his appointment and look forward to working with him during the transition,” said McMillan. “ Caleb has an impressive track record that speaks for itself and positions us well to execute on the growth strategies we put in place over the last couple of years. My time spent with Caleb gives me comfort that our customers will continue to experience the same quality of service they have been accustomed to over the years. I am very confident that his experience will allow him to build on the success that is CynergisTek today and take it to new heights tomorrow.”

 

“It has been an honor building this company, and serving our employees has been one of the great joys of my career. Handing the reins to someone like Caleb is very reassuring,” said McMillan. “He represents the best of what we have in the industry today and the kind of energy and drive in leadership CynergisTek needs to be successful in the future. I am very grateful to the men and women of CynergisTek, and to our many stakeholders. I am incredibly proud and humbled by what this team has accomplished as a business and the contributions we’ve made to healthcare. I look forward to seeing our employees develop under Caleb’s leadership as I continue to support the company in my role as a director.”

 

“Caleb is recognized as one of the leading industry experts on cybersecurity and is the perfect candidate to lead CynergisTek through the next stages of growth that includes expanding our cybersecurity, privacy and compliance services portfolio, and diversifying into new industries organically and through potential acquisitions. He has demonstrated his ability to build and grow cybersecurity businesses, lead innovative change and provide services and solutions that place a clear focus on customers,” said Abouchar. “Caleb has his finger on the pulse when it comes to understanding where cybersecurity has been and where it needs to go. Mac and the Board carefully and deliberately approached succession planning and Caleb’s appointment represents the strength and discipline of that process.”

 

Barlow is a globally recognized security professional and recently served as Vice President of Threat Intelligence for IBM Security where he built IBM’s X-Force Incident Response and Intelligence Service. He brings years of experience building security teams and defining the best practices for organizations to maintain resiliency during a security breach. Believing that a rapid, well planned and regularly rehearsed response to a cyber incident can be the difference between success and failure, Barlow


established the industry’s first immersive cyber range, the first mobile cyber operations center and a comprehensive incident command system for responding to major cyber incidents.

 

Barlow has a broad background, which he will bring to the CynergisTek team, having led teams in product development, product management, strategy, marketing, service delivery and acquisition integration. He has a history of successfully leading growth organizations and is a sought-after expert on information security with appearances that include the TED stage, the “Today” show and regular appearances on national news and dozens of publications. Caleb has testified before the U.S. Congress and the United Nations by invitation of the President of the U.N. General Assembly.

 

I am honored and humbled to be given the opportunity to lead the CynergisTek team,” said Barlow. “CynergisTek has built an incredible brand, particularly in healthcare, and I see nothing but opportunity for growth. Once again, a pure play cyber security company, CynergisTek is positioned to take maximum advantage of the opportunities ahead and I am excited about what we can accomplish.

 

“I want to extend my congratulations to Mac on his career and his leadership both here at CynergisTek and in the industry as a whole. I look forward to working with Mac and having his support on the Board.”

 

In connection with his appointment, the Company and Barlow entered into a three-year employment agreement, as well as a stock option grant agreement whereby Barlow was granted an option to purchase up to 500,000 shares of CynergisTek’s common stock, which vests over a three-year period. The stock option grant was made outside of the Company's 2011 Stock Incentive Plan and approved by the Compensation Committee of the Company's Board of Directors. CynergisTek will provide additional information regarding Barlow’s appointment in a Current Report on Form 8-K to be filed with the Securities and Exchange Commission.

 

About CynergisTek, Inc.

CynergisTek is a top-ranked cybersecurity firm dedicated to serving the information assurance needs of the healthcare industry. CynergisTek offers specialized services and solutions to help organizations achieve privacy, security, and compliance goals. Since 2004, the company has served as a partner to hundreds of healthcare organizations and is dedicated to supporting and educating the industry by contributing to relevant industry associations. The company has been recognized by KLAS in the 2016 and 2018 Cybersecurity reports as a top performing firm in healthcare cybersecurity, as well as the 2017 Best in KLAS winner for Cybersecurity Advisory Services.

Forward-Looking Statements

 

This release contains certain forward-looking statements relating to the business of CynergisTek that can be identified by the use of forward-looking terminology such as “believes,” “expects,” “anticipates,” “may” or similar expressions. Such forward-looking statements involve known and unknown risks and uncertainties, including uncertainties relating to product/service development, long and uncertain sales cycles, the ability to obtain or maintain patent or other proprietary intellectual property protection, market acceptance, future capital requirements, competition from other providers, the ability of our vendors to continue supplying the company with equipment, parts, supplies and services at comparable


terms and prices and other factors that may cause actual results to be materially different from those described herein as anticipated, believed, estimated or expected. Certain of these risks and uncertainties are or will be described in greater detail in our Form 10-K and Form 10-Q filings with the Securities and Exchange Commission, which are available at http://www.sec.gov. CynergisTek is under no obligation (and expressly disclaims any such obligation) to update or alter its forward-looking statements whether as a result of new information, future events or otherwise.

 

Investor Relations Contact:

CynergisTek, Inc.

Bryan Flynn

(512) 402-8550 x8

InvestorRelations@cynergistek.com

 

Media Contact:

Aria Marketing

Danielle Johns

(617) 332-9999 x241

djohns@ariamarketing.com